AI-generated summary
The authors report a randomized controlled trial of low-level laser therapy in 91 patients with systemic lupus erythematosus and myogenic temporomandibular disorder, comparing an active laser group with placebo and control groups. They report that the laser group had lower pain scores and better chewing performance at immediately after treatment and at one-month follow-up, which they describe as effective for one month.
- Participants
- 91
- Who or what was studied
- Patients with systemic lupus erythematosus and myogenic temporomandibular disorder
- Limits stated in the abstract
- The abstract does not report the laser wavelength, dose, or blinding, and the effect is measured only up to one month.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Visual analogue scale. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.